This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Other. Active years: 2018-2022.
Location History:
- Winter Park, FL (US) (2018)
- Orlando, FL (US) (2020 - 2022)
Company Filing History:
Years Active: 2018-2022
Title: Noreen Griffin: Innovator in Immune Response Therapies
Introduction
Noreen Griffin is a prominent inventor based in Orlando, FL (US). She has made significant contributions to the field of medical therapies, particularly in the area of immune response. With a total of 3 patents to her name, Griffin is recognized for her innovative approaches to treating various health conditions.
Latest Patents
One of Noreen Griffin's latest patents is a method for inducing a sustained immune response. This method is designed for humans or animal patients suffering from conditions such as human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), autoimmune diseases, cancer, inflammation, and neurodegenerative diseases. The method involves the daily administration of a single oral tablet, rapidly dissolving film, capsule, liquid, or cream dose of an immediate release naltrexone composition. This composition comprises between about 0.01 to about 10 mg of naltrexone, which is crucial for providing therapeutic benefits.
Career Highlights
Throughout her career, Noreen Griffin has focused on developing innovative solutions to complex medical challenges. Her work has garnered attention for its potential to improve patient outcomes in various health conditions. Griffin's dedication to research and development has positioned her as a key figure in her field.
Collaborations
Noreen Griffin has collaborated with notable professionals in her industry, including Fengping Shan and Nicholas Plotnikoff. These collaborations have further enhanced her research and contributed to the advancement of her patented methods.
Conclusion
Noreen Griffin's contributions to medical innovation, particularly in immune response therapies, highlight her role as a leading inventor. Her patents reflect a commitment to improving health outcomes for patients facing serious medical challenges. Through her work, Griffin continues to make a significant impact in the field of medical research and therapy development.